Shake-Up at Covid Vaccine Manufacturer That Tossed Millions of Doses
The Baltimore plant is one of two federally designated sites that were supposed to be ready to manufacture vaccines or therapeutics in a public health emergency. In June 2020, the Trump administration awarded Emergent a $628 million contract, mostly to reserve space in Baltimore to produce coronavirus vaccines. In Washington, Emergent is known for its…